Catalyst Wire Dossier Catalyst Wire Dossier

CD5-targeted autologous CAR T cells

CAR-T cell therapy targeting CD5 · Baylor College of Medicine
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CD5-targeted autologous CAR T cells, covering 2025-09-04 to 2025-09-04. Get the full timeline:

Most recent: Clinical Trial Update: Autologous T-Cells Expressing a Second Generation CAR for Treatment of T-Cell Malignancies Expressing CD5 Antigen [Phase 1]

See pricing